Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Chronic Migraine Patients: COMPEL Analysis by Treatment Cycle

被引：0
|
作者：
Brin, Mitchell F. [1 ,2 ]
Winner, Paul [3 ]
Blumenfeld, Andrew M. [4 ]
Eross, Eric J. [5 ]
Orejudos, Amelia [1 ]
Adams, Aubrey Manack [1 ]
机构：
[1] Allergan Plc, Irvine, CA USA
[2] Univ Calif Irvine, Irvine, CA USA
[3] Premiere Res Inst Palm Beach Neurol, Palm Beach Headache Ctr, W Palm Beach, FL USA
[4] Headache Ctr Southern Calif, Neurol Ctr, Carslbad, CA USA
[5] CORE Inst, Scottsdale, AZ USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.123
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
    Rothrock, John F.
    Luo, Lei
    Eross, Eric
    Sommer, Katherine
    Blumenfeld, Andrew M.
    NEUROLOGY, 2020, 94 (15)
  • [42] Descriptive comparison of the efficacy and safety of onabotulinumtoxina for headache prophylaxis in adult chronic migraine patients from two long-term, multicenter studies: compel vs. Preempt
    Aurora, S.
    Stark, R.
    Reppine, A.
    Adams, A. Manack
    Blumenfeld, A.
    CEPHALALGIA, 2015, 35 : 47 - 47
  • [43] Safety and tolerability of long-term albumin treatment in patients with decompensated cirrhosis
    Fernandez, Javier
    Nunez, Laura
    Costa, Montserrat
    Torres, Mireia
    Horrillo, Raquel
    Afonso, Natalia
    Mestre, Anna
    Del Arbol, Luis Ruiz
    Villanueva, Candid
    Paez, Antonio
    Arroyo, Vicente
    JOURNAL OF HEPATOLOGY, 2024, 80 : S231 - S231
  • [44] Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
    Rothrock, J. F.
    Luo, L.
    Eross, E. J.
    Sommer, K.
    Blumenfeld, A. M.
    HEADACHE, 2020, 60 : 93 - 93
  • [45] Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
    Young, William B.
    Lopez, J. Ivan
    Rothrock, John F.
    Orejudos, Amelia
    Adams, Aubrey Manack
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
  • [46] OnabotulinumtoxinA for the Treatment of Chronic Migraine
    Rothrock, John F.
    HEADACHE, 2011, 51 (04): : 659 - 660
  • [47] Descriptive Comparison of the Efficacy and Safety of OnabotulinumtoxinA for Headache Prophylaxis in Adult Chronic Migraine Patients from Two Long-term, Multicenter Studies: COMPEL vs. PREEMPT
    Aurora, S.
    Stark, R.
    Reppine, A.
    Adams, Manack A.
    Blumenfeld, A.
    HEADACHE, 2015, 55 : 142 - 142
  • [48] Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
    William B. Young
    J. Ivan Lopez
    John F. Rothrock
    Amelia Orejudos
    Aubrey Manack Adams
    Richard B. Lipton
    Andrew M. Blumenfeld
    The Journal of Headache and Pain, 2019, 20
  • [49] OnabotulinumtoxinA for Treatment of Chronic Migraine
    Markert, Ronald J.
    Solomon, Glen D.
    HEADACHE, 2011, 51 (06): : 1002 - 1003
  • [50] Eighteen-month long-term analysis of the effectiveness, safety and tolerability of subcutaneous sumatriptan in acute migraine treatment
    Gobel, H
    Stolze, H
    Heinze, A
    Dworschak, M
    Heuss, D
    Christiani, K
    Lindner, V
    NERVENARZT, 1996, 67 (06): : 471 - 483
12345